2024 Acetaminophen causes neurodevelopmental injury in susceptible babies and children: no valid rationale for controversy Corresponding author: William Parker, PhD, WPLab, Inc., 2608 Erwin Rd., STE 148-155, Durham, NC 27705, USA Email: [email protected] Received November 2, 2022 Revised February 10, 2023 Accepted May 4, 2023 Abstract Despite the worldwide acceptance of acetaminophen (APAP) as a necessary medicine in pediatrics, evidence that early exposure to APAP causes neurodevelopmental injury in susceptible babies and children has been mounting for over a decade
Gastroenterology 147 , 10731083 e1076, (2014)
E., Greinacher, A
The plaintiffs had suggested expanding the MDL to consolidate lawsuits concerning potential blood clot injuries allegedly caused by these medications
Important safety considerations include: Increased risk of hypoglycaemia when used with insulin or sulfonylureas Potential risk of pancreatitis (stop treatment and seek urgent care if suspected) Possible early worsening of diabetic retinopathy with rapid improvement in blood glucose control Risk of dehydration due to gastrointestinal side effects, particularly in hot weather Ozempic is not licensed for type 1 diabetes or diabetic ketoacidosis, and should only be used under appropriate medical supervision with regular monitoring of blood glucose levels and overall metabolic control
